Feed Articles

3 attractive emerging market stocks under $10

These 3 companies, which are offering their shares below the $10 threshold, represent key players in their respective industries. From digital payments and financial technology development in Southeast Asia, to providing advanced testing technologies for the semiconductor industry in the U.S., to innovations in imaging technology in Taiwan, these companies show how effective adaptation and innovation can create new opportunities.

This year, each of these companies has set ambitious goals for expanding their operations and improving their products, and their strategies emphasize the importance of adapting to changing market conditions.

Grab $GRAB

Grab, based in Singapore, has rapidly evolved from a simple ride-sharing service to a large-scale platform providing a wide range of services. Over the years, the company has expanded into eight Southeast Asian countries, including Indonesia, Malaysia and Thailand. With its Grab app, it offers everything from ride and delivery services to financial technology and online payments. In 2020, the company processed more than 1.9 billion transactions, allowing it to consolidate its position.

In 2023, Grab reported a profitable year, indicating the company's improving financial health. Revenues in 2023 reached $2.3 billion, representing 64% growth from the previous year. These results reflect not only a recovery from the pandemic downturn, but also the company's successful adaptation to changing market conditions.

The company plans to expand its digital payments and financial technology services, which should support further growth and increase market share. With these plans and continued expansion into new markets, Grab is ideally positioned to maintain leadership position in Southeast Asia's digital economy. This strategic direction should bring valuable opportunities for investors and support the Company's long-term growth.

InTest Corporation $INTT

Headquartered in the United States, InTest Corporation is a major player in the testing and measurement technologies for the semiconductor industry. Since its founding in 1981, the company has specialized in the manufacture and sale of test equipment that is critical to semiconductor manufacturing. Over the past decade, InTest has demonstrated robust financial performance with revenue growth that has reached 181 %, while the average growth rate of the S&P 500 index was 167%. This performance is a testament to its resilience and ability to adapt to a rapidly changing technology market.

In 2020, despite the challenges associated with the global COVID-19 pandemic, InTest maintained stable financial results and was able to maintain positive free cash flow. In 2023, the company reported revenues of $123 million and net income of 9.3 million dollars, an increase of 10% from the previous year. These results reflect strong business fundamentals and effective cost management, which allowed the company to manage market uncertainties better than many other companies in the same sector.

The company plans to invest in the development of new technologies that could improve semiconductor testing, with the aim of increasing market share and strengthening its competitive position. These investments are expected to lead to an increase in sales of 10 to 15 % in the coming year. This strategy emphasises a focus on innovation and growth, which should attract the attention of investors looking for stable yet growth opportunities in the high-tech sector.

Himax Technologies $HIMX

Himax Technologies, headquartered in Taiwan, is a major player in the semiconductor technology sector, specializing in image signal processing and display technologies. The company has quickly become a key supplier to many consumer electronics manufacturers worldwide. In 2023, Himax reported weaker results. However, it is expected strong demand for displays and image sensors.

For the past two years, the company's have been underperformingbut in 2021, Himax posted an impressive financial performance, resulting in solid profit margins and beating analysts' expectations. In the fourth quarter of 2021, the company posted earnings per share (EPS) of 18 cents, beating analyst estimates by 10 cents. The quarter also saw revenue increase by 48% compared to the same period last year, reaching a total of $365 million. This growth trend was driven by product line innovation and customer portfolio expansion. Investors and analysts, however, believe there could be a return to growth.

For future growth, Himax is emphasizing the development of new technologies and expansion into new applications such as automotive displays and virtual and augmented reality devices. The company is investing heavily in research and development to strengthen its technology capabilities and improve its product offerings. These steps are expected to enable Himax to maintain its competitive advantage and support growth, which should provide an attractive return for investors in the ever-expanding imaging technology industry.

Disclaimer: There is a lot of inspiration to be found on Bulios, but stock selection and portfolio construction is entirely up to you, so always conduct thorough self-analysis.

Source.

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy